Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Post by beercanon Sep 04, 2020 5:16am
133 Views
Post# 31509098

Today is going

Today is going To start the ball rolling 

Hermes Chan CEO at MedMira Inc I echo with Markus's comment and am very proud of our team. REVEALCOVID-19 Total Antibody Test currently has add benefit to all our end-users. This test will further meet the market expansion when the soon be made available convalescent plasma treatment and the many vaccines that have shown great results. Convalescent plasma as a therapeutic agent will require rapid answers to the presence or absence of antibodies. MedMira's batch testing capability will bring tremendous values to the blood donation clinics for screening hundreds of samples in a matter of hours (less than one minute per specimen using batch testing method) rather than days based on other traditional serological tests. As the availability of vaccine is close to a reality soon, REVEALCOVID-19 Total Antibody test will ensure 99.1% of time if the individual has had the SARS-CoV-2 antibody already prior to the vaccination. It is as well important to follow up testing of the antibody presence after vaccination to ensure if a booster is required. While SARS-CoV-2 virus is not likely to vanish anytime soon, effective and timely antibody testing may bring comfort to our children, parents, grandparents, friends and all of our love ones.
Bullboard Posts